Skip to content

SurSight® Ocular Amniotic Allograft Membrane

SKU 920050
Customer Reviews
Harnessing the power of the amniotic membrane's natural properties to provide a protective covering for use in ophthalmic applications

Why Choose SurSight®?

Amniotic membrane sheets have a long clinical history in a variety of applications. SurSight® is specifically designed to be smooth and clear for ophthalmic applications. SurSight® is minimally manipulated to retain the natural properties of the amniotic membrane, and provides clinicians with a flexible sheet that can be used in a variety of applications with ease.

SurSight® is processed into a variety of circular sizes that are tailored for use in ophthalmology. It is minimally manipulated to preserve the natural benefits of the amniotic tissue.

Product Information:

SurSight® is a dehydrated, minimally manipulated, amniotic membrane allograft for homologous use. It is shelf stable and provided in multiple sizes to provide maximum flexibility for a variety of clinical applications.

SurSight® has been specifically processed to generate a smooth, transparent finish ideal for ophthalmic applications. Our proprietary processing methods yield an irradiated product that is shelf stable and safe for use.

SurSight® is specifically formulated to be smooth and clear for ocular applications. SurSight®'s minimally manipulated process retains the therapeutic properties of the amniotic membrane and provides clinicians with a flexible sheet that can be used in a variety of treatment applications with ease. SurSight® is produced with unprecedently quality which is defined by our tightly controlled quality during production.

  • Rigorous quality and serological testing exceeding FDA requirements
  • Single layer amnion to provide a smooth and transparent finish
  • Variety of sizes tailored to accommodate ophthalmic use (5mm, 8mm, 10mm, 1mm, 12mm, 14mm, 15mm)


Surgenex is proud to be compliant with all FDA mandated current Good Tissue Practices, accredited by the American Association of Tissue Banks, and licensed with the States of California, Delaware, Illinois, New York, Oregon, Florida, and Maryland.

Minimal Manipulation

Our process extracts the membrane from the placental tissue, leaving a single amniotic membrane layer which is then dehydrated and irradiated. SurSight®‘s minimally manipulated process retains the benefits of the amniotic membrane providing clinicians with a smooth and transparent allograft ideal for ophthalmic applications.

Serological Testing

SurSight® is thoroughly tested for safety and efficacy. We pride ourselves on our tightly controlled quality processes that exceed regulatory safety requirements.